{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:00:52Z","timestamp":1781614852014,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The purpose of this study was to evaluate the relationship between triglyceride glucose (TyG)-related indices, including the TyG index and its modified versions, and the risk of developing diabetes mellitus (DM) in patients with non-alcoholic fatty liver disease (NAFLD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were sourced from the Dryad repository, comprising 2,374 individuals diagnosed with NAFLD. The TyG index was calculated using the formula: Ln [(fasting triglyceride level in mg\/dL) \u00d7 (fasting blood glucose in mg\/dL)]\/2. Modified indices were created by incorporating the TyG index with body mass index (BMI), waist circumference (WC), and waist-to-height ratio (WHtR). Logistic regression analysis and restricted cubic spline regression were utilized to investigate the association of the TyG index and modified indices with the incidence of diabetes. Predictive capabilities were evaluated through receiver operating characteristic (ROC) curve analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In multivariable logistic regression models that accounted for confounding factors, a linear correlation was identified between the TyG index and its related indices (e.g., TyG-BMI, TyG-WC, and TyG-WHtR) with the development of DM, when considered as continuous variables. Each standard deviation (SD) increase was associated with odds ratios (ORs) and 95% confidence intervals (CIs) of 1.45 (1.23\u20131.72,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), 1.57 (1.33\u20131.85,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), 1.81 (1.53\u20132.14,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), and 1.75 (1.48\u20132.06,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), respectively. The area under the curve (AUC) values for TyG, TyG-BMI, TyG-WC, and TyG-WHtR were 0.626, 0.647, 0.675, and 0.681, respectively, indicating that the TyG-related indices had higher AUC values than TyG alone. Stratified analyses revealed a positive correlation between TyG-related indices and DM among NAFLD patients with various characteristics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A linear and positive correlation was observed between TyG-related parameters and the risk of incident DM. Among NAFLD patients, the TyG-BMI, TyG-WC, and TyG-WHtR indices were found to be more effective clinical predictors than the TyG index alone for forecasting the onset of DM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s42000-025-00710-x","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:32:49Z","timestamp":1754487169000},"page":"1055-1065","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of TyG-related indices with incident DM among NAFLD patients: a retrospective study"],"prefix":"10.1007","volume":"24","author":[{"given":"Yuanyang","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"710_CR1","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc25-S002","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee (2025) 2. Diagnosis and classification of diabetes: standards of care in Diabetes-2025. Diabetes Care 48:S27\u2013s49. https:\/\/doi.org\/10.2337\/dc25-S002","journal-title":"Diabetes Care"},{"key":"710_CR2","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.2337\/dci23-0036","volume":"46","author":"DB Sacks","year":"2023","unstructured":"Sacks DB, Arnold M, Bakris GL et al (2023) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 46:e151\u2013e199. https:\/\/doi.org\/10.2337\/dci23-0036","journal-title":"Diabetes Care"},{"key":"710_CR3","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","volume":"119","author":"C Grander","year":"2023","unstructured":"Grander C, Grabherr F, Tilg H (2023) Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovasc Res 119:1787\u20131798. https:\/\/doi.org\/10.1093\/cvr\/cvad095","journal-title":"Cardiovasc Res"},{"key":"710_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW Wong","year":"2023","unstructured":"Wong VW, Ekstedt M, Wong GL et al (2023) Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol 79:842\u2013852. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.036","journal-title":"J Hepatol"},{"key":"710_CR5","doi-asserted-by":"publisher","unstructured":"Wu Y, Li L, Jiang Y (2024) DM incidence in lean NAFLD. Diabetes research and clinical practice 207:111089. https:\/\/doi.org\/10.1016\/j.diabres.2024.111089","DOI":"10.1016\/j.diabres.2024.111089"},{"key":"710_CR6","doi-asserted-by":"publisher","first-page":"986","DOI":"10.47391\/jpma.22-63","volume":"72","author":"VK Ramdas Nayak","year":"2022","unstructured":"Ramdas Nayak VK, Satheesh P, Shenoy MT et al (2022) Triglyceride glucose (TyG) index: a surrogate biomarker of insulin resistance. JPMA J Pakistan Med Association 72:986\u2013988. https:\/\/doi.org\/10.47391\/jpma.22-63","journal-title":"JPMA J Pakistan Med Association"},{"key":"710_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-022-01548-y","volume":"21","author":"J Zhao","year":"2022","unstructured":"Zhao J, Fan H, Wang T et al (2022) TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol 21:123. https:\/\/doi.org\/10.1186\/s12933-022-01548-y","journal-title":"Cardiovasc Diabetol"},{"key":"710_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12933-022-01732-0","volume":"22","author":"Y Yang","year":"2023","unstructured":"Yang Y, Huang X, Wang Y et al (2023) The impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis. Cardiovasc Diabetol 22:2. https:\/\/doi.org\/10.1186\/s12933-022-01732-0","journal-title":"Cardiovasc Diabetol"},{"key":"710_CR9","doi-asserted-by":"publisher","first-page":"951689","DOI":"10.3389\/fendo.2022.951689","volume":"13","author":"Y Xue","year":"2022","unstructured":"Xue Y, Xu J, Li M et al (2022) Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: triglyceride glucose index-related parameters. Front Endocrinol 13:951689. https:\/\/doi.org\/10.3389\/fendo.2022.951689","journal-title":"Front Endocrinol"},{"key":"710_CR10","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.26355\/eurrev_202207_29191","volume":"26","author":"EG Alkurt","year":"2022","unstructured":"Alkurt EG, \u00d6zkan MB, Turhan VB (2022) Predictive value of triglyceride\/glucose index (TyG) in predicting breast cancer in patients with breast mass. Eur Rev Med Pharmacol Sci 26:4671\u20134676. https:\/\/doi.org\/10.26355\/eurrev_202207_29191","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"710_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jpeds.2021.11.042","volume":"242","author":"K Song","year":"2022","unstructured":"Song K, Park G, Lee HS et al (2022) Comparison of the triglyceride glucose index and modified triglyceride glucose indices to predict nonalcoholic fatty liver disease in youths. J Pediatr 242:79\u201385e71. https:\/\/doi.org\/10.1016\/j.jpeds.2021.11.042","journal-title":"J Pediatr"},{"key":"710_CR12","doi-asserted-by":"publisher","first-page":"e943375","DOI":"10.12659\/msm.943375","volume":"30","author":"K Trochimczyk","year":"2024","unstructured":"Trochimczyk K, Flisiak-Jackiewicz M, Bobrus-Chociej A et al (2024) Biochemical and anthropometric indices of insulin resistance in obese and overweight children with metabolic dysfunction-associated fatty liver disease. Med Sci Monitor: Int Med J Experimental Clin Res 30:e943375. https:\/\/doi.org\/10.12659\/msm.943375","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"key":"710_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41366-018-0076-3","volume":"43","author":"T Okamura","year":"2019","unstructured":"Okamura T, Hashimoto Y, Hamaguchi M et al (2019) Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes 43:139\u2013148. https:\/\/doi.org\/10.1038\/s41366-018-0076-3","journal-title":"Int J Obes"},{"key":"710_CR14","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.2337\/diacare.25.7.1252","volume":"25","author":"T Ota","year":"2002","unstructured":"Ota T, Takamura T, Hirai N et al (2002) Preobesity in world health organization classification involves the metabolic syndrome in Japanese. Diabetes Care 25:1252\u20131253. https:\/\/doi.org\/10.2337\/diacare.25.7.1252","journal-title":"Diabetes Care"},{"key":"710_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1373\/clinchem.2006.078980","volume":"53","author":"S Ryu","year":"2007","unstructured":"Ryu S, Chang Y, Kim DI et al (2007) gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 53:71\u201377. https:\/\/doi.org\/10.1373\/clinchem.2006.078980","journal-title":"Clin Chem"},{"key":"710_CR16","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S et al (2019) The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Research: Official J Japanese Soc Hypertens 42:1235\u20131481. https:\/\/doi.org\/10.1038\/s41440-019-0284-9","journal-title":"Hypertens Research: Official J Japanese Soc Hypertens"},{"key":"710_CR17","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee (2022) 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2022. Diabetes Care 45:S17\u2013s38. https:\/\/doi.org\/10.2337\/dc22-S002","journal-title":"Diabetes Care"},{"key":"710_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/m16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P (2017) Sensitivity analysis in observational research: introducing the E-Value. Ann Intern Med 167:268\u2013274. https:\/\/doi.org\/10.7326\/m16-2607","journal-title":"Ann Intern Med"},{"key":"710_CR19","doi-asserted-by":"publisher","unstructured":"Kim HS, Cho YK, Kim EH et al (2021) Triglyceride glucose-waist circumference is superior to the homeostasis model assessment of insulin resistance in identifying nonalcoholic fatty liver disease in healthy subjects. Journal of clinical medicine 11. https:\/\/doi.org\/10.3390\/jcm11010041","DOI":"10.3390\/jcm11010041"},{"key":"710_CR20","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3389\/fphar.2018.01566","volume":"9","author":"W Mu","year":"2018","unstructured":"Mu W, Cheng XF, Liu Y et al (2018) Potential nexus of non-alcoholic fatty liver disease and type 2 diabetes mellitus: insulin resistance between hepatic and peripheral tissues. Front Pharmacol 9:1566. https:\/\/doi.org\/10.3389\/fphar.2018.01566","journal-title":"Front Pharmacol"},{"key":"710_CR21","doi-asserted-by":"publisher","unstructured":"Reidy PT, Edvalson LT, McKenzie AI et al (2020) Neuromuscular electrical stimulation and protein during bed rest increases CD11b(+) skeletal muscle macrophages but does not correspond to muscle size or insulin sensitivity. Applied physiology, nutrition, and metabolism\u2009=\u2009physiologie appliquee, nutrition et metabolisme. 45:1261\u20131269. https:\/\/doi.org\/10.1139\/apnm-2020-0064","DOI":"10.1139\/apnm-2020-0064"},{"key":"710_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1055\/s-0028-1091981","volume":"28","author":"J Jou","year":"2008","unstructured":"Jou J, Choi SS, Diehl AM (2008) Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 28:370\u2013379. https:\/\/doi.org\/10.1055\/s-0028-1091981","journal-title":"Semin Liver Dis"},{"key":"710_CR23","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","volume":"62","author":"S McPherson","year":"2015","unstructured":"McPherson S, Hardy T, Henderson E et al (2015) Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol 62:1148\u20131155. https:\/\/doi.org\/10.1016\/j.jhep.2014.11.034","journal-title":"J Hepatol"},{"key":"710_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12944-020-01403-7","volume":"19","author":"X Li","year":"2020","unstructured":"Li X, Li G, Cheng T et al (2020) Association between triglyceride-glucose index and risk of incident diabetes: a secondary analysis based on a Chinese cohort study: TyG index and incident diabetes. Lipids Health Dis 19:236. https:\/\/doi.org\/10.1186\/s12944-020-01403-7","journal-title":"Lipids Health Dis"},{"key":"710_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ypmed.2016.01.022","volume":"86","author":"D Navarro-Gonz\u00e1lez","year":"2016","unstructured":"Navarro-Gonz\u00e1lez D, S\u00e1nchez-\u00cd\u00f1igo L, Pastrana-Delgado J et al (2016) Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: the vascular-metabolic CUN cohort. Prev Med 86:99\u2013105. https:\/\/doi.org\/10.1016\/j.ypmed.2016.01.022","journal-title":"Prev Med"},{"key":"710_CR26","doi-asserted-by":"publisher","first-page":"1191090","DOI":"10.3389\/fendo.2023.1191090","volume":"14","author":"L Rong","year":"2023","unstructured":"Rong L, Hou N, Hu J et al (2023) The role of TyG index in predicting the incidence of diabetes in Chinese elderly men: a 20-year retrospective study. Front Endocrinol 14:1191090. https:\/\/doi.org\/10.3389\/fendo.2023.1191090","journal-title":"Front Endocrinol"},{"key":"710_CR27","doi-asserted-by":"publisher","first-page":"108533","DOI":"10.1016\/j.diabres.2020.108533","volume":"171","author":"JA Kim","year":"2021","unstructured":"Kim JA, Kim J, Roh E et al (2021) Triglyceride and glucose index and the risk of gestational diabetes mellitus: a nationwide population-based cohort study. Diabetes Res Clin Pract 171:108533. https:\/\/doi.org\/10.1016\/j.diabres.2020.108533","journal-title":"Diabetes Res Clin Pract"},{"key":"710_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12944-021-01532-7","volume":"20","author":"X Wang","year":"2021","unstructured":"Wang X, Liu J, Cheng Z et al (2021) Triglyceride glucose-body mass index and the risk of diabetes: a general population-based cohort study. Lipids Health Dis 20:99. https:\/\/doi.org\/10.1186\/s12944-021-01532-7","journal-title":"Lipids Health Dis"},{"key":"710_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:299\u2013304. https:\/\/doi.org\/10.1089\/met.2008.0034","journal-title":"Metab Syndr Relat Disord"},{"key":"710_CR30","doi-asserted-by":"publisher","first-page":"e90430","DOI":"10.1371\/journal.pone.0090430","volume":"9","author":"SH Lee","year":"2014","unstructured":"Lee SH, Kwon HS, Park YM et al (2014) Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju metabolic disease cohort (CMC) study. PLoS ONE 9:e90430. https:\/\/doi.org\/10.1371\/journal.pone.0090430","journal-title":"PLoS ONE"},{"key":"710_CR31","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jhep.2022.01.010","volume":"76","author":"F Petermann-Rocha","year":"2022","unstructured":"Petermann-Rocha F, Gray SR, Forrest E et al (2022) Associations of muscle mass and grip strength with severe NAFLD: a prospective study of 333,295 UK biobank participants. J Hepatol 76:1021\u20131029. https:\/\/doi.org\/10.1016\/j.jhep.2022.01.010","journal-title":"J Hepatol"},{"key":"710_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2147\/dmso.S399275","volume":"16","author":"J Mao","year":"2023","unstructured":"Mao J, Gan S, Zhou Q et al (2023) Optimal anthropometric indicators and cut points for predicting metabolic syndrome in Chinese patients with type 2 diabetes mellitus by gender. Diabetes Metabolic Syndrome Obesity: Targets Therapy 16:505\u2013514. https:\/\/doi.org\/10.2147\/dmso.S399275","journal-title":"Diabetes Metabolic Syndrome Obesity: Targets Therapy"},{"key":"710_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13098-018-0376-8","volume":"10","author":"SH Khan","year":"2018","unstructured":"Khan SH, Sobia F, Niazi NK et al (2018) Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr 10:74. https:\/\/doi.org\/10.1186\/s13098-018-0376-8","journal-title":"Diabetol Metab Syndr"},{"key":"710_CR34","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.2147\/dmso.S433493","volume":"16","author":"Y Xing","year":"2023","unstructured":"Xing Y, Liu J, Gao Y et al (2023) Stronger associations of TyG index with diabetes than TyG-obesity-related parameters: more pronounced in young, middle-aged, and women. Diabetes Metabolic Syndrome Obesity: Targets Therapy 16:3795\u20133805. https:\/\/doi.org\/10.2147\/dmso.S433493","journal-title":"Diabetes Metabolic Syndrome Obesity: Targets Therapy"},{"key":"710_CR35","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s40519-021-01238-w","volume":"27","author":"P Ke","year":"2022","unstructured":"Ke P, Wu X, Xu M et al (2022) Comparison of obesity indices and triglyceride glucose-related parameters to predict type 2 diabetes mellitus among normal-weight elderly in China. Eat Weight Disorders: EWD 27:1181\u20131191. https:\/\/doi.org\/10.1007\/s40519-021-01238-w","journal-title":"Eat Weight Disorders: EWD"},{"key":"710_CR36","doi-asserted-by":"publisher","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","volume":"11","author":"LK Er","year":"2016","unstructured":"Er LK, Wu S, Chou HH et al (2016) Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE 11:e0149731. https:\/\/doi.org\/10.1371\/journal.pone.0149731","journal-title":"PLoS ONE"},{"key":"710_CR37","doi-asserted-by":"publisher","first-page":"862919","DOI":"10.3389\/fendo.2022.862919","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Sun M, Yang Y et al (2022) Predictive effect of triglyceride glucose-related parameters, obesity indices, and lipid ratios for diabetes in a Chinese population: a prospective cohort study. Front Endocrinol 13:862919. https:\/\/doi.org\/10.3389\/fendo.2022.862919","journal-title":"Front Endocrinol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-025-00710-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-025-00710-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-025-00710-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:43:35Z","timestamp":1781613815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-025-00710-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["710"],"URL":"https:\/\/doi.org\/10.1007\/s42000-025-00710-x","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Murakami Memorial Hospital\u2019s ethical committee. Since this study is a post-hoc analysis of the NAGALA study, therefore, no separate ethical approval is required. The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors agree to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflict of interest in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}